The Efficacy of Immunotherapy in Long-Term Survival in Non-Small Cell Lung Cancer (NSCLC) Associated with the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).
Roxana-Andreea Rahnea-NitaAlexandru-Rares StoianRodica-Maricela AnghelLaura-Florentina RebegeaAnda-Natalia CiuhuXenia-Elena BacinschiAnca Florina ZguraOana-Gabriela TrifanescuRadu-Valeriu TomaGeorgiana Bianca ConstantinGabriela Rahnea-NitaPublished in: Life (Basel, Switzerland) (2023)
Each patient must be approached individually, taking into account the various particular aspects. Immunotherapy proves to be the innovative treatment that contributes to increasing the survival of patients with metastatic non-small cell lung cancer and to increasing their quality of life.